By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada Ltd. (KMDA) Awarded European Orphan Drug Designation For Its Alpha-1 Antitrypsin To Treat Graft-Versus-Host Disease 3/23/2015 11:03:22 AM
Kamada Ltd. (KMDA) Strengthens Leadership Team With The Addition Of Vice President-Medical Director 3/11/2015 10:27:34 AM
Kamada Ltd. (KMDA) Reports 2014 Fourth Quarter And Full Year Financial Results 2/11/2015 12:00:48 PM
Kamada Ltd. (KMDA) Reports Encouraging Interim Data From Its Phase 1/2 Extension Study: AAT In Pediatric Patients With Type 1 Diabetes 2/2/2015 10:29:29 AM
Kamada Ltd. (KMDA) Reports Encouraging Discussions With European Co-Rapporteurs Regarding European Filing For Inhaled Alpha-1 Antitrypsin To Treat AATD 1/7/2015 10:27:53 AM
Kamada Ltd. (KMDA) Announces Positive Interim Results From Phase 1/2 Clinical Study Of Its Human Alpha-1 Antitrypsin To Treat Graft-Versus-Host Disease Presented At American Society of Hematology Annual Meeting 12/11/2014 7:21:59 AM
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014 9:51:20 AM
Kamada Ltd. (KMDA) To Host Third Quarter 2014 Financial Results Conference Call On November 12, 2014 11/10/2014 10:13:57 AM
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014 8:39:28 AM
Kamada Ltd. (KMDA) Announces Study In Support Of Alpha-1 Antitrypsin For The Treatment Of Type-1 Diabetes Published In The Journal Of Diabetes Science And Technology 10/21/2014 11:06:15 AM